Skip to main content
Clinical Trials/NCT01484106
NCT01484106
Completed
N/A

Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Severe Sepsis

Cheetah Medical Inc.12 sites in 1 country65 target enrollmentNovember 2011
ConditionsSepsis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Sepsis
Sponsor
Cheetah Medical Inc.
Enrollment
65
Locations
12
Primary Endpoint
sequential organ failure assessment score increases by greater or equal to 1 point from the baseline score within 72 hours of study enrollment.
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The primary objective of this study is to test whether a fluid resuscitation protocol guided by non-invasive hemodynamic measures reduces the progression of organ dysfunction (defined by an increase in the Serial Organ Failure Assessment Score ≥ 1 over the first 72 hours) in sepsis patients presenting to the Emergency Department without evidence of shock.

Registry
clinicaltrials.gov
Start Date
November 2011
End Date
August 2014
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Cheetah Medical Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adult patients \> 18 years with old suspected or confirmed infection
  • At least two of the following four criteria (SIRS):
  • Temperature \> 38 or \< 36o C
  • Heart rate \> 90 bpm
  • Respiratory rate \> 20 bpm or PaCO2\< 32 mmHg
  • White blood cell count \>12,000 or \<4,000 per mm3; or \>10% bandemia
  • Lactate ≥2.0 and ≤4.0 mMol/L
  • Enrollment within 6 hours of ED presentation within 2.5 hours of meeting eligibility criteria

Exclusion Criteria

  • Age \< 18 years
  • On vasopressor therapy
  • Systolic blood pressure \< 90 mmHg
  • Received more than 3-liter crystalloid fluid prior to randomization
  • Patient presenting with pulmonary edema
  • Patient presenting with acute coronary syndrome
  • Patient presenting with new onset cardiac arrhythmia
  • Patient presenting with trauma, including burns
  • Patient requires immediate surgery
  • Patient presenting with stroke

Outcomes

Primary Outcomes

sequential organ failure assessment score increases by greater or equal to 1 point from the baseline score within 72 hours of study enrollment.

Time Frame: 72 hours

A patient will be considered to have progressive organ dysfunction if their "Sequential Organ Failure Assessment" (SOFA) score increases by ≥1 point from their baseline score within 72 hours of study enrollment.

Study Sites (12)

Loading locations...

Similar Trials